These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36124848)

  • 1. Strain-to-strain variability among Staphylococcus aureus causing prosthetic joint infection drives heterogeneity in response to levofloxacin and rifampicin.
    Meléndez-Carmona MÁ; Mancheño-Losa M; Ruiz-Sorribas A; Muñoz-Gallego I; Viedma E; Chaves F; Van Bambeke F; Lora-Tamayo J
    J Antimicrob Chemother; 2022 Nov; 77(12):3265-3269. PubMed ID: 36124848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerant Small-colony Variants Form Prior to Resistance Within a Staphylococcus aureus Biofilm Based on Antibiotic Selective Pressure.
    Manasherob R; Mooney JA; Lowenberg DW; Bollyky PL; Amanatullah DF
    Clin Orthop Relat Res; 2021 Jul; 479(7):1471-1481. PubMed ID: 33835090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomics of Staphylococcus aureus and Staphylococcus epidermidis from Periprosthetic Joint Infections and Correlation to Clinical Outcome.
    Trobos M; Firdaus R; Svensson Malchau K; Tillander J; Arnellos D; Rolfson O; Thomsen P; Lasa I
    Microbiol Spectr; 2022 Aug; 10(4):e0218121. PubMed ID: 35762769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection.
    Meléndez-Carmona MÁ; Muñoz-Gallego I; Viedma E; Lora-Tamayo J; Chaves F
    Int J Antimicrob Agents; 2019 Sep; 54(3):356-360. PubMed ID: 31254616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of Staphylococcus epidermidis within Biofilms: Comparison of Systemic versus Supratherapeutic Concentrations of Antibiotics.
    Daffinee KE; Piehl EC; Bleick C; LaPlante KL
    Antimicrob Agents Chemother; 2023 Jun; 67(6):e0010823. PubMed ID: 37154699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of linezolid or trimethoprim/sulfamethoxazole in combination with rifampicin as alternative oral treatments based on an in vitro pharmacodynamic model of staphylococcal biofilm.
    El Haj C; Murillo O; Ribera A; Lloberas N; Gómez-Junyent J; Tubau F; Fontova P; Cabellos C; Ariza J
    Int J Antimicrob Agents; 2018 Jun; 51(6):854-861. PubMed ID: 29374577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does a New Antibiotic Scheme Improve the Outcome of
    Auñón Á; Tovar-Bazaga M; Blanco-García A; García-Cañete J; Parrón R; Esteban J
    Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus.
    Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A
    Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilm formation is associated with poor outcome in prosthetic joint infections caused by
    Hagstrand Aldman M; Thompson O; Påhlman LI
    Infect Dis (Lond); 2023 May; 55(5):328-332. PubMed ID: 36799228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifamycin resistance, rpoB gene mutation and clinical outcomes of Staphylococcus species isolates from prosthetic joint infections in Republic of Korea.
    Lee Y; Kim SS; Choi SM; Bae CJ; Oh TH; Kim SE; Kim UJ; Kang SJ; Jung SI; Park KH
    J Glob Antimicrob Resist; 2022 Mar; 28():43-48. PubMed ID: 34920175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention.
    Lora-Tamayo J; Murillo O; Iribarren JA; Soriano A; Sánchez-Somolinos M; Baraia-Etxaburu JM; Rico A; Palomino J; Rodríguez-Pardo D; Horcajada JP; Benito N; Bahamonde A; Granados A; del Toro MD; Cobo J; Riera M; Ramos A; Jover-Sáenz A; Ariza J;
    Clin Infect Dis; 2013 Jan; 56(2):182-94. PubMed ID: 22942204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Bacteriophage Anti-Biofilm Activity for Potential Control of Orthopedic Implant-Related Infections Caused by Staphylococcus aureus.
    Morris J; Kelly N; Elliott L; Grant A; Wilkinson M; Hazratwala K; McEwen P
    Surg Infect (Larchmt); 2019 Jan; 20(1):16-24. PubMed ID: 30207891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of resistance mechanisms and biological characteristics of rifampicin-resistant Staphylococcus aureus strains selected in vitro.
    Wang C; Fang R; Zhou B; Tian X; Zhang X; Zheng X; Zhang S; Dong G; Cao J; Zhou T
    BMC Microbiol; 2019 Sep; 19(1):220. PubMed ID: 31533633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for the presence of persisters across clinical presentations.
    Bär J; Boumasmoud M; Mairpady Shambat S; Vulin C; Huemer M; Schweizer TA; Gómez-Mejia A; Eberhard N; Achermann Y; Zingg PO; Mestres CA; Brugger SD; Schuepbach RA; Kouyos RD; Hasse B; Zinkernagel AS
    Clin Microbiol Infect; 2022 Jul; 28(7):1022.e1-1022.e7. PubMed ID: 35124264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real time monitoring of Staphylococcus aureus biofilm sensitivity towards antibiotics with isothermal microcalorimetry.
    Sultan AR; Tavakol M; Lemmens-den Toom NA; Croughs PD; Verkaik NJ; Verbon A; van Wamel WJB
    PLoS One; 2022; 17(2):e0260272. PubMed ID: 35171906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Planktonic and biofilm states of Staphylococcus aureus isolated from bone and joint infections and the in vitro effect of orally available antibiotics.
    Perez-Alba E; Flores-Treviño S; Villarreal-Salazar V; Bocanegra-Ibarias P; Vilchez-Cavazos F; Camacho-Ortiz A
    J Appl Microbiol; 2023 Dec; 134(12):. PubMed ID: 37977856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Susceptibility of Staphylococcus aureus biofilms to vancomycin, gemtamicin and rifampin].
    Kotulová D; Slobodníková L
    Epidemiol Mikrobiol Imunol; 2010 Apr; 59(2):80-7. PubMed ID: 20586169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of biofilm on the in vitro activity of vancomycin alone and in combination with tigecycline and rifampicin against Staphylococcus aureus.
    Rose WE; Poppens PT
    J Antimicrob Chemother; 2009 Mar; 63(3):485-8. PubMed ID: 19109338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of Exebacase (CF-301) against Biofilms Formed by Staphylococcus epidermidis Strains Isolated from Prosthetic Joint Infections.
    Souche A; Kolenda C; Teoli J; Schuch R; Ferry T; Laurent F; Josse J
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0058822. PubMed ID: 35861539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis.
    Lourtet-Hascoët J; Bicart-See A; Félicé MP; Giordano G; Bonnet E
    Int J Infect Dis; 2016 Oct; 51():56-61. PubMed ID: 27609028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.